![]() | |
Clinical data | |
---|---|
AHFS/ Drugs.com | Multum Consumer Information |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C6H11NO3 |
Molar mass | 145.158 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix.
Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser.
Metvix is developed by Photocure and Galderma has bought all rights to Metvix. [1]
Methyl aminolevulinate is approved in New Zealand for treatment of basal cell carcinoma. [2]
It is now approved in many countries and has been used to treat non-melanoma skin cancer (including basal cell carcinoma). [3]
It has some advantages over Levulan. [4]
It has been reported as controversial in some quarters, with severe pain allegedly being experienced by some patients. [5]
![]() | |
Clinical data | |
---|---|
AHFS/ Drugs.com | Multum Consumer Information |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C6H11NO3 |
Molar mass | 145.158 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix.
Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser.
Metvix is developed by Photocure and Galderma has bought all rights to Metvix. [1]
Methyl aminolevulinate is approved in New Zealand for treatment of basal cell carcinoma. [2]
It is now approved in many countries and has been used to treat non-melanoma skin cancer (including basal cell carcinoma). [3]
It has some advantages over Levulan. [4]
It has been reported as controversial in some quarters, with severe pain allegedly being experienced by some patients. [5]